Portal de investigación
An open-label study for participants who are non-responders at the end of treatment assessment on the VRDN-001-101 and VRDN-001-301 pivotal studies.
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
VIRIDIAN THERAPEUTICS, INC.
Cita
An open-label study for participants who are non-responders at the end of treatment assessment on the VRDN-001-101 and VRDN-001-301 pivotal studies. (VRDN-001-302). Viridian Therapeutics, Inc. 2024IP:MARTA PÉREZ LÓPEZ.